All About Multiple Sclerosis

More MS news articles for February 2004

Teva Neuroscience & Country Music Star Clay Walker Expand National Multiple Sclerosis Awareness Campaign

Multi-platinum recording artist to take personal battle with MS on nationwide MS Road Tour to offer inspiration and hope

Monday February 23, 2004
Source: Teva Neuroscience, Inc.

Teva Neuroscience, Inc. announced today that the company is extending its partnership with multi-platinum country recording artist Clay Walker for another year. Teva Neuroscience and Walker are joining forces to raise awareness about MS and the importance of early initiation of treatment.

"I want to educate others about the treatment options available and encourage them to find an option that works for them," said Walker. "The worst thing you can do if you have MS is nothing. Early treatment is the best weapon we have until we find a cure. While people can respond differently to treatment, I'm grateful to have found a therapy that along with diet and exercise has allowed me to continue the career I love."

Walker has announced plans to share his unique message of hope and inspiration with thousands of people living with MS through a multi-city, nationwide MS Road Tour. Walker plans to make numerous stops around the country where he will speak at MS patient programs, participate in fundraisers for MS research, and appear at other MS-related functions. The MS Road Tour will be in addition to Walker's national concert tour, where he'll be promoting his newest RCA Records album, A Few Questions, and his latest single.

"I feel fortunate that I've been able to manage my MS with such success, which has allowed me to continue the career I love," Walker said. "I owe this to the research that developed Copaxone® (glatiramer acetate injection), the drug therapy I take every day, and the lifestyle changes I've made. Through the MS Road Tour, I want to not only raise awareness and funding for research but also inspire others to realize this diagnosis does not mean you have to give up your dreams."

Walker's partnership with Teva Neuroscience is just one of the many ways he has decided to be visible in the fight against MS. Last year, Walker revealed for the first time publicly his eight-year journey with relapsing-remitting MS and announced his mission to help others living with the disease. His first step was the creation of the Band Against MS(SM) Foundation, a not-for-profit organization dedicated to raising funds for MS research which Walker launched last February.

In addition, Walker has spoken at MS educational seminars, addressed members of Congress about new legislation for those living with MS, completed TV and radio public service announcements (PSAs) to support the MS cause, and helped raise funds for MS research through his foundation, which gave its first annual research grant to the University of Texas Medical School in Houston.

Walker's emerging status as a leader within the MS community was recently recognized by the National Multiple Sclerosis Society (NMSS) which presented him its most prestigious award - Ambassador of the Year - for his work to educate people about the importance of taking an active role in managing their MS. Walker became only the fourth person in the society's 57-year history to receive this distinction.

"Being named Ambassador of the Year by the National MS Society was a tremendous honor for me," said Walker who received the award last November. "It showed me the impact I can have on the MS community by sharing my story. I believe it's my responsibility to use whatever influence I have to help make a difference."

Since he began his career in 1993, Walker has had 11 No. 1 singles and has been one of country music's top-10 grossing touring acts. In September, he released A Few Questions with a career best debut of No. 3 on the Billboard album sales charts. This release, which was his first for RCA Records, adds to the more than 8 million albums he has sold.

More information about Walker and his 2004 concert touring schedule is available at

Copyright © 2004, PRNewswire